InsiderClue
Stocks · Health care · Pharmaceutical Preparations

FibroBiologics, Inc.

FBLG Clue Score47
United States Fiscal year ends December CIK 0001958777
$1.13 +1.80% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.13 +131.84% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 31 Jan 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2022Operating income−4.5Net income−5.1EPS, diluted−0.18Fiscal year 2023Operating income−8.9Net income−16.5EPS, diluted−0.68Fiscal year 2024Operating income−13.7Net income−11.2EPS, diluted−0.34Fiscal year 2025Operating income−16.6Net income−18.6EPS, diluted−0.42
FY2022FY2023FY2024FY2025
Operating income −4.5 −8.9 −13.7 −16.6
Net income −5.1 −16.5 −11.2 −18.6
Growth
EPS, diluted −0.18 −0.68 −0.34 −0.42
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−4.1Fiscal year 2023Operating cash flow−6.4Capital expenditure−0.5Free cash flow−6.9Fiscal year 2024Operating cash flow−11.9Capital expenditure−0.2Free cash flow−12.1Fiscal year 2025Operating cash flow−16.4Capital expenditure−0.3Free cash flow−16.7
FY2022FY2023FY2024FY2025
Operating cash flow −4.1 −6.4 −11.9 −16.4
Capital expenditure n/a −0.5 −0.2 −0.3
Free cash flow n/a −6.9 −12.1 −16.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash2.3Shareholders’ equity−4.0Fiscal year 2023Cash9.2Shareholders’ equity1.3Fiscal year 2024Cash14.0Shareholders’ equity2.7Fiscal year 2025Cash4.9Shareholders’ equity6.2
FY2022FY2023FY2024FY2025
Cash 2.3 9.2 14.0 4.9
Shareholders’ equity −4.0 1.3 2.7 6.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
2.3 9.2 14.0 4.9
0.3 n/a n/a n/a
n/a 0.8 0.8 0.8
4.8 11.8 16.4 9.6
Growth +145.0% +39.1% −41.5%
Liabilities
8.8 10.6 13.7 3.5
Equity
−7.9 −24.4 −35.5 −54.2
−4.0 1.3 2.7 6.2
Growth +118.3% +125.1%
Per share and net cash
n/a 32.6 37.7 67.6
calc n/a 0.04 0.07 0.09

Lines marked calc are worked out here from filed figures; point at one for how.